A Validated Risk Model for Overall Survival in Relapsed/Refractory Chronic Lymphocytic Leukemia Applicable to Patients Treated with Novel Therapies and Standard of Care
暂无分享,去创建一个
Jeffrey A Jones | J. Byrd | A. Zelenetz | M. Hallek | A. Chanan-Khan | A. Howes | R. Furman | A. Ni | J. Sharman | P. Hillmen | A. Londhe | V. Reddy | J. Soumerai | Ming Lin | L. Dreiling | M. Darif | R. Dubowy | D. James | G. Xing | H. Adewoye | Lucille Ferrante | Julie Huang